 | Ovid Therapeutics Inc (NASDAQ:OVID) Expected to Announce Earnings of -$0.43 Per Share
www.americanbankingnews.com - February 16 at 4:18 AM |
| Ovid Therapeutics Inc (NASDAQ:OVID) Short Interest Up 5.8% in January
www.americanbankingnews.com - February 15 at 3:26 AM |
| Ovid Therapeutics Inc (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 10 at 9:47 AM |
 | Here Are Some Valentine’s Day Lessons From 43 BC Roman Poet Ovid
www.forbes.com - February 5 at 7:29 PM |
 | With strong work ethic and play, Justin Moore keying perfect start for Ovid-Elsie hoops
www.msn.com - January 31 at 12:50 AM |
| Short Interest in Ovid Therapeutics Inc (NASDAQ:OVID) Rises By 234.6%
www.americanbankingnews.com - January 26 at 8:16 PM |
 | Is Ovid Therapeutics (NASDAQ:OVID) In A Good Position To Invest In Growth?
finance.yahoo.com - January 10 at 5:17 PM |
| BRIEF-Ovid Therapeutics Provides Update On Multiple Clinical Data Readouts Across Rare Neurological Disease Platform
www.msn.com - January 7 at 5:26 PM |
| Ovid Therapeutics Provides 2020 Update in Preparation for Multiple Clinical Data Readouts Across Rare Neurological Disease Platform
finance.yahoo.com - January 7 at 5:26 PM |
| Hedge Funds Have Never Been More Bullish On Ovid Therapeutics Inc. (OVID)
finance.yahoo.com - December 19 at 11:30 PM |
| Is Travelzoo Inc. (TZOO) A Good Stock To Buy?
finance.yahoo.com - December 16 at 9:20 AM |
| RBC: 3 “Strong Buy” Stocks That Could Step on the Gas in 2020
finance.yahoo.com - December 6 at 1:54 PM |
 | RBC bullish on OVID's 2020 catalysts
seekingalpha.com - November 29 at 7:50 AM |
| Ovid Therapeutics to Participate at the 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 26 at 8:23 AM |
| Ovid Therapeutics Appoints Jason Tardio as Chief Commercial Officer
finance.yahoo.com - November 18 at 8:26 PM |
| Ovid Therapeutics EPS misses by $0.06
seekingalpha.com - November 8 at 12:27 PM |
| Ovid Therapeutics Reports Third Quarter 2019 Financial Results and Recent Progress
finance.yahoo.com - November 8 at 12:27 PM |
| Executives on the move at Ovid Therapeutics
seekingalpha.com - November 1 at 2:03 PM |
| Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts Expected in 2020
finance.yahoo.com - November 1 at 9:02 AM |
| Jeremy Levin Is The Chairman & CEO of Ovid Therapeutics Inc. (NASDAQ:OVID) And They Just Spent US$150k On Shares
finance.yahoo.com - October 12 at 1:29 PM |
| Ovid Therapeutics, Sunrun, Pure Cycle, and Other 13D Filings
finance.yahoo.com - October 11 at 10:33 PM |
 | OVID Ovid Therapeutics Inc. Common Stock
www.nasdaq.com - October 6 at 8:47 AM |
 | Mid-Day Market Update: Dow Rises Over 200 Points; Ovid Therapeutics Shares Plunge
www.benzinga.com - October 4 at 4:05 PM |
| Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
finance.yahoo.com - October 4 at 4:05 PM |
| Ovid -13% on common, preferred offerings
seekingalpha.com - October 3 at 5:08 PM |
| Will Ovid Therapeutics Continue to Surge Higher?
finance.yahoo.com - September 24 at 5:33 PM |
| Ovid up 7% on positive soticlestat data
seekingalpha.com - September 23 at 3:41 PM |
| Ovid Therapeutics Announces Positive Initial Data from Ongoing ENDYMION Open-Label Extension Trial of Soticlestat in People with Rare Epilepsies
finance.yahoo.com - September 23 at 10:40 AM |
| Could The Ovid Therapeutics Inc. (NASDAQ:OVID) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - September 21 at 12:28 AM |
| Ovid Therapeutics: High Risk/High Reward
seekingalpha.com - September 16 at 12:33 PM |
| Enrollment underway in late-stage study of Ovid's gaboxadol in Angelman
seekingalpha.com - September 13 at 9:29 AM |
| Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 9 at 8:49 AM |
| Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences
finance.yahoo.com - September 3 at 10:49 AM |
 | Metabolomics Biomarker Market to Receive Overwhelming Hike in Revenues by 2025
www.marketwatch.com - August 27 at 5:59 PM |
| Ovid Therapeutics Reports Second Quarter 2019 Financial Results and Highlights Recent Progress
finance.yahoo.com - August 7 at 5:16 PM |
| Ovid Therapeutics: Lack Of Clear Efficacy Signals Do Not Look Convincing
seekingalpha.com - August 2 at 6:50 PM |
| Some Ovid Therapeutics (NASDAQ:OVID) Shareholders Have Taken A Painful 71% Share Price Drop
finance.yahoo.com - July 9 at 5:21 PM |
| Ovid up 10% on advancement of OV101 in Angelman
seekingalpha.com - July 2 at 5:21 PM |
| Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101 for the Treatment of Angelman Syndrome
finance.yahoo.com - July 2 at 9:47 AM |
| Ovid Therapeutics Initiates Pivotal Phase 3 Clinical Trial in Angelman Syndrome; Multiple Data Readouts Across Rare Neurological Disease Pipeline Expected in 2H 2019 and Early 2020
finance.yahoo.com - June 27 at 9:58 AM |
| Ovid Therapeutics to Host R&D Day on June 27, 2019
finance.yahoo.com - June 18 at 6:10 PM |
| BIO Elects Dr. Jeremy Levin as New Board Chair
www.marketwatch.com - June 4 at 9:51 AM |
| Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium
finance.yahoo.com - May 23 at 6:04 PM |
| Ovid Therapeutics: Multiple Ways To Win In This Beaten-Down Biotech
seekingalpha.com - May 8 at 6:14 PM |
| Angelman syndrome
www.benzinga.com - May 7 at 9:41 AM |
| Ovid Therapeutics misses by $0.05
seekingalpha.com - May 7 at 9:41 AM |
| Ovid Therapeutics Rallies On Rare Genetic Disorder Drug Data
finance.yahoo.com - May 7 at 9:41 AM |
| Ovid Therapeutics Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 7 at 9:41 AM |
| Ovid up 16% on OV101 data in rare inherited disorders
seekingalpha.com - May 6 at 9:48 AM |
| Have Insiders Been Buying Ovid Therapeutics Inc. (NASDAQ:OVID) Shares This Year?
finance.yahoo.com - April 27 at 4:39 PM |
